Nature Communications · 11 Nov 2026
Pharmacological chaperone treatment with Cystadane in aspartylglucosaminuria: an open-label, phase Ib/II trial
Minna Laineh-index 2, Antje Banning, Viljami Sairanen, Günter Lochnit, Timo Roine, Elina L. Harjunen, Ulrika Roine, Anna M. Tokola, Hanna Terinkoski, Daniel Leufkens, Päivi Helenius, Taina H. Autti, Ritva Tikkanenh-index 34
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Abstract This phase Ib/II investigator-initiated, open label trial aims to show the safety and efficacy of Cystadane (betaine) in aspartylglucosaminuria, a lysosomal storage disorder characterized by progressive cognitive decline, in Finnish patients homozygous for the Finnish major mutation, aged between 3 and 17 years at study begin (recruited: 25, analyzed: 21). Oral Cystadane efficacy and safety were studied over 48 months. The primary endpoint of the study, reduction of glycoasparagines in the urine, was quantitatively determined using liquid chromatography/mass spectrometry and normalized to urine creatinine. Urine glycoasparagines are significantly reduced upon Cystadane treatment (by 68.6% ±10.8%; p = 0.000), and the study thus meets its primary endpoint. Our data show that Cystadane/betaine efficiently improves the main disease biomarker, and it is safe to use in aspartylglucosaminuria. Further studies should be carried out in a larger patient population over a longer time to demonstrate the effects on disease progression. EudraCT registration number 2017-000645-48.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Ritva Tikkanen has the highest h-index among the authors (34).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (71)
What it cites, from open citation data, with Crossref's record of each.
Sign in to see 51 more references
A free account opens the rest of the citing papers and references on every paper’s page.